BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2081227)

  • 1. Avenues for acquired immune tolerance.
    Wood KJ; Morris PJ
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):189-97. PubMed ID: 2081227
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies of immunosuppression in cardiac transplantation.
    Renlund DG; O'Connell JB; Bristow MR
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
    Renlund DG; O'Connell JB; Bristow MR
    J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion.
    Xu H; Gundry SR; Hancock W; Matsumiya G; Bailey LL
    Transplant Proc; 2000 Aug; 32(5):1084-5. PubMed ID: 10936368
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction therapy: why, when, and which agent?
    Krischock L; Marks SD
    Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
    Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
    Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression for heart transplantation.
    White DJ
    Br J Biomed Sci; 1993 Sep; 50(3):277-83. PubMed ID: 7694717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute rejection.
    Adams DH; Neuberger JM
    Semin Liver Dis; 1992 Feb; 12(1):80-8. PubMed ID: 1570553
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
    Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
    Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
    Frist WH; Merrill WH; Eastburn TE; Atkinson JB; Stewart JR; Hammon JW; Bender JW
    J Heart Transplant; 1990; 9(5):489-94. PubMed ID: 2121921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
    Kormos RL; Herlan DB; Armitage JM; Stein K; Kaufman C; Zeevi A; Duquesnoy R; Hardesty RL; Griffith BP
    J Heart Transplant; 1990; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute.
    Beaufigeau M; Dumesnil D; Carrier M; White M; Pelletier GB
    Transplant Proc; 1997 Nov; 29(7A):10S-12S. PubMed ID: 9366918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive therapy in transplantation surgery].
    Padberg W; Schwemmle K; Dobroschke J; Kupiec-Weglinski JW; Tilney NL
    Dtsch Med Wochenschr; 1987 Oct; 112(43):1670-4. PubMed ID: 3311694
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.